Search by Drug Name
A B C D E F G H I J K L M N O P Q R S T U V W X Y ZClinical Trials for ZIPRASIDONE HYDROCHLORIDE
- A Study of the Efficacy of Fecal Microbiota Transplantation(FMT) in the Treatment of Schizophrenia
- A Prospective, Open-ended, Multi-center Study of Schizophrenia Patients Switching to Zolodine
- Reducing the Abuse Liability of Prescription Opioids
- Atypical Antipsychotics Influence on the Safety of the Heart and Monitoring Indicators Model Building
- The Treatment Efficacy of Combination Atypical Antipsychotics With Sertraline in Patients With Schizophrenia
- Proposal To Develop A Rapid And Cost-Effective Diagnostic Test For Schizophrenia
- Extension Study Evaluating The Safety And Tolerability Of Flexible Doses Of Oral Ziprasidone In Children And Adolescents With Bipolar I Disorder
- A Study to Assess the Safety and Efficacy of ASP4345 as Add-on Treatment for Cognitive Impairment in Subjects With Schizophrenia on Stable Doses of Antipsychotic Medication
- Saxenda® in Obese or Overweight Patients With Stable Bipolar Disorder (Investigator Initiated)
- Melatonin Use in the Intensive Care Elderly Population
- Gene-by-Stress Interactions in Intervention Studies Significance
- The Efficacy And Safety Of Intramuscular Ziprasidone For Three Days In Patients With Psychotic Agitation
- Longitudinal Comparative Effectiveness of Bipolar Disorder Therapies
- The Role of miR-30 Family Dysregulation in Response to Antipsychotic Treatment
- Family Intervention in Recent Onset Schizophrenia Treatment (FIRST)
- Antipsychotics and Risk of Hyperglycemic Emergencies
- Neurocognitive Effectiveness in Treatment of First-episode Non-affective Psychosis: 1-year Follow-up
- Comparative Study of Aripiprazole, Quetiapine and Ziprasidone in Treatment of First Episode Psychosis: 3-year Follow-up
- Metformin for Overweight & OBese ChILdren and Adolescents With BDS Treated With SGAs
- Pharmacovigilance in Gerontopsychiatric Patients
- The Role of Chronotropic Incompetence in Heart Failure With Normal Ejection Fraction (HFNEF)
- Evaluation of the Necessity of Long-term Pharmacological Treatment With Antipsychotics in Schizophrenic Patients
- Comparative Study of Aripiprazole, Quetiapine and Ziprasidone in the Treatment of First Episode Nonaffective Psychosis
- Study of the Effects of Pantoprazole on Levels of Prescribed Psychiatric Medications
- A Randomized Double-blind Trial With 6 Antipsychotic Drugs for Schizophrenia
- Efficacy and Safety Trial of Flexible Doses of Oral Ziprasidone in Children and Adolescents With Bipolar I Disorder
- Comparative Efficacy and Acceptability of Antimanic Drugs in Acute Mania
- 1/2-MC4R Genotype and Pediatric Antipsychotic Drug- Induced Weight Gain
- Trial Comparing Haloperidol, Quetiapine and Placebo in the Pharmacological Treatment of Delirium
- Clinical Trial to Evaluate the Efficacy of Treatment vs Discontinuation in a First Episode of Non-affective Psychosis
- Pioglitazone for the Treatment of Bipolar Depression
- Safety and Efficacy of Aripiprazole and Ziprasidone Among Schizophrenic Patients With Metabolic Syndrome
- Bioequivalence Study of Ziprasidone HCL Capsules, 20 mg of Dr. Reddy's Under Fed Conditions
- Bioequivalence Study of Ziprasidone HCL Capsules, 20 mg Under Fasting Conditions
- An Observational Drug Utilization Study of Asenapine in the United Kingdom (P08308)
- Four Interventions in the Management of Psychomotor Agitation, Safety and Efficacy Evaluation
- Acute Impact of Intramuscular (IM) Aripiprazole and Olanzapine on Insulin Resistance in High Risk Prediabetics
- Ziprasidone Switching in Response to Adherence and Psychotropic-Related Weight Gain Concerns Among Patients With Bipolar Disorder (Zip Ad)
- The Modifying the Impact of ICU-Associated Neurological Dysfunction-USA (MIND-USA) Study
- Effectiveness of Ziprasidone for Patients With Schizophrenia
- Antipsychotics and Gene Expression in Soft Tissues
- Ziprasidone in Bipolar Disorder With Comorbid Lifetime Panic or Generalized Anxiety Disorder(GAD)
- Predictors of Response to Augmentation With Ziprasidone (Geodon®) in Major Depressive Disorder
- Efficacy and Safety With Ziprasidone in First-episode Psychosis
- Safety And Tolerability Of Flexible Doses Of Oral Ziprasidone In Children And Adolescents With Bipolar I Disorder (Manic Or Mixed)
- Safety And Efficacy Of Ziprasidone In Children And Adolescents With Bipolar I Disorder (Manic Or Mixed) (Protocol A1281196)
- One-Year Trial of Oral Ziprasidone in Bipolar Patients With Metabolic Syndrome
- A Non-Interventional Post-Marketing Surveillance Study to Evaluate the Safety and Efficacy of Zeldox Capsule
- Ziprasidone in Early Onset Schizophrenia Spectrum Disorders
- Mood Stabilizer (MS)+ Antidepressant vs MS + Placebo in Maintenance of Bipolar Disorder.
- Use, Effects and Side-effects of Second-generation Antipsychotics in a Naturalistic Setting
- Healthy Volunteers Study of the Effects of Olanzapine and Ziprasidone
- Examining the Effects of Antipsychotic Medications on Insulin Sensitivity
- An Investigation of Sleep Architecture in Ziprasidone-Treated Bipolar Depression
- Omega-3 Fatty Acids (Lovaza) for Second Generation Antipsychotic-Associated Hypertriglyceridemia
- Ziprasidone Pharmacokinetics Using a Reduced Food Effect Formulation Compared to Pharmacokinetics From Commercial Capsules
- 24-Hour Time Course of Striatal Dopamine D2 Receptor Occupancy of Ziprasidone: A PET Study
- Ziprasidone vs Standard Therapy for Agitated Patients in the ED
- One-Year Trial Of Oral Ziprasidone In Patients With Metabolic Syndrome
- A Randomized, Open-Label, Multi-Center Study To Evaluate The Efficacy And Safety Of Intramuscular Ziprasidone In Patients With Agitation
- Ziprasidone for Severe Conduct and Other Disruptive Behavior Disorders
- A 12-Week, Placebo Controlled Trial of Ziprasidone as Monotherapy for Major Depressive Disorder
- Ranolazine Versus Placebo Effects on Exercise Tolerance in Patients With Heart Disease and Peripheral Arterial Disease
- A Study of the Safety and Tolerability of Oral Ziprasidone in Children and Teens With Psychotic Disorders
- A Study of the Efficacy and Safety of Ziprasidone for the Treatment of Acute Exacerbation of Schizophrenia or Schizoaffective Disorder
- A Study Comparing the Efficacy and Tolerability of Ziprasidone vs. Clozapine for the Treatment of Schizophrenia in Patients Who Continue to Have Symptoms on or Cannot Tolerate Other Antipsychotic Drugs
- A Study of the Effects of Ziprasidone for the Treatment of Schizophrenia or Schizoaffective Disorder in Patients Who Were Switched From Other Antipsychotic Drugs
- A Study Comparing the Safety and Efficacy of Ziprasidone and Risperidone for the Treatment of Chronic Schizophrenia
- A Study to Compare the Efficacy and Safety of Ziprasidone and Risperidone for the Treatment of Schizophrenia in Chinese Patients
- A Study of Ziprasidone for the Treatment of Psychosis in Patients Who Had Already Had Benefits From Ziprasidone Treatment in a Previous Study
- A Study of the Efficacy and Safety of Ziprasidone in Patients With Acute Exacerbation of Schizophrenia or Schizoaffective Disorder
- A Study of the Efficacy and Safety of Intramuscular Ziprasidone Followed by Oral Ziprasidone for the Treatment of Psychosis
- Ziprasidone in the Treatment of Borderline Personality Disorder
- Ziprasidone in the Psychosis Prodrome
- A Study Comparing the Efficacy and Safety of Ziprasidone and Aripiprazole for the Treatment fo Schizophrenia or Schizoaffective Disorder in Hospitalized Patients
- Ziprasidone Augmentation of SSRIs for Patients With Major Depressive Disorder (MDD) That do Not Sufficiently Respond to Treatment With SSRIs
- Ziprasidone in Pediatric Bipolar Disorder
- Improving Metabolic Parameters of Antipsychotic Child Treatment With Ziprasidone, Aripiprazole, and Clozapine
- Treatment of Schizophrenic Patients With Ziprasidone
- A 12-Week, Placebo Controlled Trial of Ziprasidone as Monotherapy for Major Depressive Disorder
- Improving Diabetes Risk Factors in Persons With Schizophrenia or Bipolar Disorder by Switching to Ziprasidone
- Glucose and Lipid Metabolism on Antipsychotic Medication
- Use of Galantamine and CDP-choline (Citicoline) to Treat Adults With Schizophrenia
- Safety Study of Ziprasidone (Geodon) for the Depressive Mixed State
- The Paliperidone ER Observational Study of Economic, Functional, and Clinical Outcomes in Patients With Schizophrenia
- Adjunctive Ziprasidone in the Treatment of Bipolar I Depression
- Geodon in Weight Loss Study for Bipolar Disorders
- Efficacy and Tolerability of Switching to Ziprasidone From Other Antipsychotics
- Non-interventional Study of Ziprasidone in the Treatment of Bipolar and Schizoaffective Disorders.
- Open-label Ziprasidone Study for Psychosis Treatment in Adolescents
- Large Simple Trial (LST) Of Cardiovascular Safety Of Ziprasidone And Olanzapine- (Zodiac)
- Study Evaluating The Safety, Tolerability, And Efficacy Of Switching From Quetiapine To Ziprasidone
- High-Dose Oral Ziprasidone Versus Conventional Dosing in Participants With Residual Schizophrenia Symptoms
- Effect of Ziprasidone on Glucose & Plasma Lipids in Diabetes (II) and Schizophrenia or Schizoaffective Disorder
- Ziprasidone for the Treatment of Generalized Anxiety in Patients With Bipolar Disorder
- Ziprasidone for Clozapine- or Olanzapine-Associated Diabetes Mellitus
- Switch Study of Existing Atypical Antipsychotics to Bifeprunox
- Ziprasidone vs. Sertraline/Haloperidol in Psychotic Depression
- Ziprasidone for Improving Insulin Sensitivity in People With Schizophrenia Who Are at Risk for Diabetes
- Preventing Relapse in Schizophrenia: Oral Antipsychotics Compared To Injectables: Evaluating Efficacy
- Ziprasidone And Olanzapine's Outcomes In Mania
- Body Mass Index (BMI) and Metabolic Changes Following Switch to Aripiprazole From Olanzapine, Risperidone and Quetiapine
- 3-week Study to Evaluate Efficacy and Safety of Ziprasidone With Either Lithium or Divalproex in Acutely Manic Subjects
- A Study to Evaluate the Efficacy and Safety of Adjustable Doses of Extended-release (ER) Paliperidone Compared With Placebo, in Combination With Lithium or Valproate, to Treat Manic and Mixed Episodes in Patients With Bipolar I Disorder
- Influence of Treatment With Olanzapine or Ziprasidone on Transcapillary Glucose Transport in Human Skeletal Muscle
- Anticonvulsant Mood Stabilizers, Antipsychotic Drugs and the Insulin Resistance Syndrome
- Aripiprazole in the Treatment of Acutely Relapsed Patients With Schizophrenia
- A Six-week Flexible Dose Study Evaluating the Efficacy and Safety of Geodon in Patients With Bipolar I Depression.
- Safety and Maintenance of Effect of Ziprasidone Plus a Mood Stabilizer in Bipolar I Disorder (Manic or Mixed)
- Safety And Tolerability Of Ziprasidone In Adolescents With Schizophrenia
- Safety and Tolerability of Ziprasidone in Children and Adolescents With Bipolar I Disorder (Manic or Mixed)
- Safety And Efficacy Of Ziprasidone In Adolescents With Schizophrenia
- Safety and Efficacy of Ziprasidone in Children and Adolescents With Bipolar I Disorder (Manic or Mixed)
- Trial of Aripiprazole in the Treatment of CD in Adolescents
- Ziprasidone and Sertraline in PTSD
- Ziprasidone Versus Olanzapine In The Treatment Of Schizophrenia.
- Open-Label Study of Geodon in Non-Rapid Cycling Bipolar II Patients With Major Depression
- Treatment With Ziprasidone for Schizophrenia Patients With Obsessive Compulsive Disorder (OCD)
- Neurocognitive Effects of Ziprasidone: Relationship to Working Memory and Dopamine Blockade
- Clozapine-Augmentation With Ziprasidone or Risperidone, a Randomized, Prospective Trial
- Geodon for the Treatment of Refractory Social Anxiety Disorder
- Ziprasidone in Children With Autism: A Pilot Study
- Aripiprazole in Children With Autism: A Pilot Study
- Geodon (Ziprasidone) for Posttraumatic Stress Disorder
- The CAMPUS Project: Cholinergic Augmentation of Cognitive Deficits in Schizophrenia
- Pfizer/IVGTT/Ziprasidone/Olanzapine
- Changes in Adiposity, Metabolic Measures From Atypicals to Aripiprazole
- Safety And Efficacy Study Of Ziprasidone In Pediatric Psychotic Illness
- Clinical Trial With Ziprasidone for the Treatment of Psychiatric Pathology Associated to Alcoholism
- Ziprasidone for the Treatment of Mania in Children and Adolescents With Bipolar Disorder
- Extension Study of Patients Successfully Treated by Ziprasidone in Study A1281031
- Effect And Safety Of Ziprasidone Compared To Other Atypical Antipsychotic Drug In Schizophrenic Patients
- 12 Week Open, Non-Comparative Switch Study Of Oral Ziprazidone In Previously Treated Schizophrenic Patients
- Energy Homeostasis Under Treatment With Atypical Antipsychotics
- Kahn Study; Investigation Of The Efficacy Of Ziprasidone Versus Olanzapine In The Management Of Recent-Onset Psychosis; A Flexible-Dose, Parallel Group, Double-Blind Study
- Mozart Relapse Study
- A Six-Week Study Evaluating The Efficacy And Safety Of Geodon In Patients With A Diagnosis Of Bipolar I Depression
- Extension Study: Evaluating the Safety of Oral Ziprasidone in the Treatment of Subjects With Schizophrenia
- Clinical Effect Of Cross Titration Of Antipsychotics With Ziprasidone In Schizophrenia Or Schizoaffective Disorder
- IM and Oral in Acute Exacerbation of Schizophrenia (BIZET Study)
- Study of Licarbazepine in the Treatment of Manic Episodes of Bipolar Disorder
- The MIND Study: Modifying the INcidence of Delirium
- Treatment and Outcome of Early Onset Bipolar Disorder
- Switching Medication to Treat Schizophrenia
- Olanzapine Versus Active Comparator in the Treatment of Depression in Patients With Schizophrenia
- CATIE- Schizophrenia Trial
Clinical trials list
click for details